353504-67-3Relevant academic research and scientific papers
COMPOUNDS, COMPOSITIONS AND METHODS
-
, (2008/06/13)
The present invention provides methods and pharmaceutical compositions for inhibiting expressions of HIF and HIF regulated genes, inhibiting angiogenesis, inducing cell cycle arrest in tumor cells, and treating cell proliferating diseases or conditions.
A Convenient Route to the Soluble Guanylate Cyclase Activator YC-1 and its N2 Regioisomer
Fernandez, Patricia A.,Bellamy, Tom,Kling, Marcel,Madge, David J.,Selwood, David L.
, p. 1813 - 1816 (2007/10/03)
A new route to the soluble guanylate cyclase (sGC) activator YC-1 and its N2 regioisomer has been established with a Mitsunobu mediated N-alkylation as the key step. The route is utilised in the synthesis of a potential photoaffinity label.
